The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Tuberculosis (TB) Diagnostics-Global Market Insights and Sales Trends 2025
Synopsis
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global Tuberculosis (TB) Diagnostics market size is expected to reach US$ 3592.2 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Tuberculosis (TB) Diagnostics in various end use industries. The expanding demands from the Diagnostic Laboratories and Hospitals, are propelling Tuberculosis (TB) Diagnostics market. Culture-Based Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sputum Smear Microscopy segment is estimated at % CAGR for the next seven-year period.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tuberculosis (TB) Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tuberculosis (TB) Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tuberculosis (TB) Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tuberculosis (TB) Diagnostics covered in this report include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux and Hain Lifescience, etc.
The global Tuberculosis (TB) Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Global Tuberculosis (TB) Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tuberculosis (TB) Diagnostics market, Segment by Type:
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Global Tuberculosis (TB) Diagnostics market, by Application
Diagnostic Laboratories
Hospitals
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Tuberculosis (TB) Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global Tuberculosis (TB) Diagnostics market size is expected to reach US$ 3592.2 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Tuberculosis (TB) Diagnostics in various end use industries. The expanding demands from the Diagnostic Laboratories and Hospitals, are propelling Tuberculosis (TB) Diagnostics market. Culture-Based Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sputum Smear Microscopy segment is estimated at % CAGR for the next seven-year period.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tuberculosis (TB) Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tuberculosis (TB) Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tuberculosis (TB) Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tuberculosis (TB) Diagnostics covered in this report include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux and Hain Lifescience, etc.
The global Tuberculosis (TB) Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Global Tuberculosis (TB) Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tuberculosis (TB) Diagnostics market, Segment by Type:
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Global Tuberculosis (TB) Diagnostics market, by Application
Diagnostic Laboratories
Hospitals
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Tuberculosis (TB) Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Tuberculosis (TB) Diagnostics
1.1 Tuberculosis (TB) Diagnostics Market Overview
1.1.1 Tuberculosis (TB) Diagnostics Product Scope
1.1.2 Tuberculosis (TB) Diagnostics Market Status and Outlook
1.2 Global Tuberculosis (TB) Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Tuberculosis (TB) Diagnostics Market Size by Region (2018-2029)
1.4 Global Tuberculosis (TB) Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Tuberculosis (TB) Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Tuberculosis (TB) Diagnostics Market Size (2018-2029)
1.6.1 North America Tuberculosis (TB) Diagnostics Market Size (2018-2029)
1.6.2 Europe Tuberculosis (TB) Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size (2018-2029)
1.6.4 Latin America Tuberculosis (TB) Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size (2018-2029)
2 Tuberculosis (TB) Diagnostics Market by Type
2.1 Introduction
2.1.1 Culture-Based Diagnostics
2.1.2 Sputum Smear Microscopy
2.1.3 Rapid Molecular Diagnostics
2.1.4 Others
2.2 Global Tuberculosis (TB) Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Tuberculosis (TB) Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Tuberculosis (TB) Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Tuberculosis (TB) Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Breakdown by Type (2018-2029)
3 Tuberculosis (TB) Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic Laboratories
3.1.2 Hospitals
3.2 Global Tuberculosis (TB) Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Tuberculosis (TB) Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Tuberculosis (TB) Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Tuberculosis (TB) Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Breakdown by Application (2018-2029)
4 Tuberculosis (TB) Diagnostics Competition Analysis by Players
4.1 Global Tuberculosis (TB) Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2022)
4.3 Date of Key Players Enter into Tuberculosis (TB) Diagnostics Market
4.4 Global Top Players Tuberculosis (TB) Diagnostics Headquarters and Area Served
4.5 Key Players Tuberculosis (TB) Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Tuberculosis (TB) Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Danaher
5.1.1 Danaher Profile
5.1.2 Danaher Main Business
5.1.3 Danaher Tuberculosis (TB) Diagnostics Products, Services and Solutions
5.1.4 Danaher Tuberculosis (TB) Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Danaher Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Tuberculosis (TB) Diagnostics Products, Services and Solutions
5.2.4 Roche Tuberculosis (TB) Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Profile
5.3.2 Thermo Fisher Scientific Main Business
5.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Products, Services and Solutions
5.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 BD Recent Developments
5.4 BD
5.4.1 BD Profile
5.4.2 BD Main Business
5.4.3 BD Tuberculosis (TB) Diagnostics Products, Services and Solutions
5.4.4 BD Tuberculosis (TB) Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 BD Recent Developments
5.5 Abbott
5.5.1 Abbott Profile
5.5.2 Abbott Main Business
5.5.3 Abbott Tuberculosis (TB) Diagnostics Products, Services and Solutions
5.5.4 Abbott Tuberculosis (TB) Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Recent Developments
5.6 Hologic
5.6.1 Hologic Profile
5.6.2 Hologic Main Business
5.6.3 Hologic Tuberculosis (TB) Diagnostics Products, Services and Solutions
5.6.4 Hologic Tuberculosis (TB) Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Hologic Recent Developments
5.7 Qiagen
5.7.1 Qiagen Profile
5.7.2 Qiagen Main Business
5.7.3 Qiagen Tuberculosis (TB) Diagnostics Products, Services and Solutions
5.7.4 Qiagen Tuberculosis (TB) Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Qiagen Recent Developments
5.8 BioMerieux
5.8.1 BioMerieux Profile
5.8.2 BioMerieux Main Business
5.8.3 BioMerieux Tuberculosis (TB) Diagnostics Products, Services and Solutions
5.8.4 BioMerieux Tuberculosis (TB) Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 BioMerieux Recent Developments
5.9 Hain Lifescience
5.9.1 Hain Lifescience Profile
5.9.2 Hain Lifescience Main Business
5.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Products, Services and Solutions
5.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Hain Lifescience Recent Developments
5.10 Oxford Immunotec
5.10.1 Oxford Immunotec Profile
5.10.2 Oxford Immunotec Main Business
5.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Products, Services and Solutions
5.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Oxford Immunotec Recent Developments
6 North America
6.1 North America Tuberculosis (TB) Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Tuberculosis (TB) Diagnostics Market Dynamics
11.1 Tuberculosis (TB) Diagnostics Industry Trends
11.2 Tuberculosis (TB) Diagnostics Market Drivers
11.3 Tuberculosis (TB) Diagnostics Market Challenges
11.4 Tuberculosis (TB) Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
